AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research

Article

The AACR and the Prevent Cancer Foundation are pleased to co-sponsor this major international Award in recognition of outstanding cancer prevention research.

The AACR and the Prevent Cancer Foundation are pleased to co-sponsor this major international Award in recognition of outstanding cancer prevention research. The AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research is given to a scientist residing in any country in the world for his or her seminal contributions to the field of cancer prevention. Such investigations must have been conducted in basic, translational, clinical, epidemiological, or behavioral science in cancer prevention research. Further, these studies must have had not only a major impact on the field, but must also have stimulated new directions in this important area.

The recipient of the Award will receive a $5,000 honorarium and present a 50-minute lecture at the 8th Annual AACR International Conference on Frontiers in Cancer Prevention Research. The Conference will be held December 6-9, 2009, at the Hilton Americas, Houston, TX.

The nomination deadline is Friday, July 31, 2009.

For more information: http://www.aacr.org/home/scientists/scientific-achievement-awards/prevent-cancer-award.aspx

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content